TMCnet News
Increasing Demand for Personalized Medicines Will Spur Growth in the Global Proteomics Market by 2019: TechnavioThe popularity of personalized medicine has resulted in the growth of the global proteomics market, which is expected to post a CAGR of 8.39% from 2015-2019, says research firm Technavio. About the Report A defect in a particular protein structure can result in specific conditions and disorders. Thus, the development of new and personalized drugs depends on the identification and study of protein expression. "Personalized medicines have high market demand in the oncology therapeutics area, and many incentives are also provided by manufacturers for cancer therapies," says Faisal Ghaus, Vice President of Technavio. The latest Technavio report also draws attention towards the shift from genomics to proteomics. More biological function is carried out by dynamic protein population than static genome, which only represents the first layer of complexity. Therefore, the proteome is a highly dynamic entity, which changes as per the cellular and extracellular state of the human body. "The post-genomic era is characterized by the study of prteomics and encourages researchers to think in an interdisciplinary manner in order to discover novel proteins," says Ghaus. Market Scope and Calculation of Market Size This report covers the current scenario and growth prospects of the global proteomics market from 2015-2019. To calculate the market size, the report considers the revenue generated from two segments: equipment and consumables. Key Information Covered in the Report:
Technavio currently has more than 3000 market research reports on a huge range of topics, including 50+ reports on the proteomics market: If you are interested in more information, please contact our media team at [email protected].
|
